Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences